Tag Archive for: Governor Tom Wolf

Posts

Iovance Biotherapeutics Announces New Facility at the Navy Yard to Support U.S. Production of Tumor Infiltrating Lymphocyte Cell Therapy Products

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it has entered into a lease agreement to build an approximately 136,000 square foot commercial-scale production facility at the Philadelphia Navy Yard for commercial and clinical production of autologous TIL products, including its candidate lifileucel. Read more

Adaptimmune Growth Leads to Long-Term Expansion Plans in Philadelphia at The Navy Yard

Adaptimmune Therapeutics plc. (“Adaptimmune” or the “Company”), a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced plans to locate its U.S. headquarters and clinical operations in a newly developed facility to be constructed at The Navy Yard in Philadelphia. The 47,400 square foot facility, located at 351 Rouse Boulevard in The Navy Yard’s Corporate Center, will house a state-of-the-art cGMP manufacturing facility designed to support the clinical development and initial commercialization of the Company’s novel engineered immunotherapies for cancer.  Read more

Navy Yard

The Navy Yard is considered the most successful redevelopment of a former military facility in the country and today is a growing community where companies and their employees thrive. Future growth will support up to 10 million square feet of commercial and residential development.

COPYRIGHT © PIDC ALL RIGHTS RESERVED – DESIGNED BY LEVLANE